Indications & Uses
Pralidot is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Adults and children over 16 years: Give an initial dose of 1000 to 2000 mg of Pralidox (Pralidoxime Chloride), preferably as an infusion in 100 ml of normal saline over 15 to 30 minutes. If this is not practical, or if pulmonary oedema is present, give the dose slowly by intravenous injection (over not less than 5 minutes) as a 50 mg/ml solution (for example, 1000 mg in 20 ml). A second dose of 1000 to 2000 mg may be needed after about one hour if muscle weakness has not been relieved. Further doses may be given every 10 to 12 hours if muscle weakness persists. Children 16 years and under: Loading dose: 20 to 50 mg/kg (maximum 2000 mg per dose) over 15 to 30 minutes. Maintenance infusion: 10 to 20 mg/kg per hour. Alternatively, a repeat bolus of 20 to 50 mg/kg (maximum 2000 mg per dose) may be given after 1 hour and repeated every 10 to 12 hours thereafter, as needed. Preparation for administration: For intravenous infusion, reconstitute a single Pralidox (Pralidoxime Chloride) 1000 mg vial by adding 20 ml of Normal Saline (0.9% Sodium Chloride solution) for Injection using a 10 ml syringe; this gives a concentration of 50 mg/ml. Dilute the solution further with the remaining Normal Saline to reach a concentration of 10 to 20 mg/ml (for example, 1000 mg in 100 ml or 2000 mg in 100 ml). For fluid-restricted patients, or for rapid administration (over at least 5 minutes), a maximum concentration of 50 mg/ml may be used. Discard any unused solution once the dose has been withdrawn.
Side Effects
In a few cases, side effects such as a rapid heartbeat (tachycardia), spasm of the voice box (laryngospasm) and muscle stiffness (rigidity) have been linked to injecting the medicine too quickly.
Cautions & Contraindications
Warnings & Precautions
The following precautions should be kept in mind when treating acetylcholinesterase poisoning, although they do not bear directly on the use of Pralidox. Because barbiturates are potentiated by anticholinesterases, they should be used cautiously in the treatment of convulsions. Morphine, theophylline, aminophylline, succinylcholine, reserpine and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning. Prolonged paralysis has been reported in patients when succinylcholine is given together with drugs that have anticholinesterase activity; it should therefore be used with caution.
Contraindications
Do not use Pralidoxime Chloride if you are allergic (hypersensitive) to pralidoxime or any other ingredient in the product.